research-article

You have full text access to this OnlineOpen article

Directed Sibling Cord Blood Banking for Transplantation: The 10-Year Experience in the National Blood Service in England

  1. Jon Smythe MPhil, Ph.D.1,*,
  2. Sue Armitage2,
  3. Dorothy McDonald1,
  4. Derwood Pamphilon3,
  5. Martin Guttridge1,
  6. Juliette Brown4,
  7. Ann Green4,
  8. Colin Brown4,
  9. Ruth M. Warwick5,
  10. Alan Lankester1,
  11. Deirdre Fehily2,
  12. Marcela Contreras6,
  13. Cristina Navarrete4,7,
  14. Suzanne M. Watt1,8

Article first published online: 17 MAY 2007

DOI: 10.1634/stemcells.2007-0063

Issue

STEM CELLS

STEM CELLS

Volume 25, Issue 8, pages 2087–2093, August 2007

Additional Information

How to Cite

Smythe, J., Armitage, S., McDonald, D., Pamphilon, D., Guttridge, M., Brown, J., Green, A., Brown, C., Warwick, R. M., Lankester, A., Fehily, D., Contreras, M., Navarrete, C. and Watt, S. M. (2007), Directed Sibling Cord Blood Banking for Transplantation: The 10-Year Experience in the National Blood Service in England. STEM CELLS, 25: 2087–2093. doi: 10.1634/stemcells.2007-0063

Author Information

  1. 1

    Stem Cells and Immunotherapies Department, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

  2. 2

    National Health Service Cord Blood Bank, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

  3. 3

    Bristol Institute of Transfusion Sciences, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

  4. 4

    Histocompatibility and Immunogenetics Department, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

  5. 5

    Tissue Services Department, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

  6. 6

    Division of Diagnostics, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

  7. 7

    Department of Immunology and Molecular Pathology, University College London, London, United Kingdom

  8. 8

    Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, United Kingdom

*Stem Cells and Immunotherapies Department, National Blood Service, NHS Blood and Transplant, Headington, Oxford OX3 9BQ, U.K. Telephone: 44-0-1865-44-79-67; Fax: 44-0-1865-44-79-77

Publication History

  1. Issue published online: 2 JAN 2009
  2. Article first published online: 17 MAY 2007
  3. Manuscript Accepted: 20 APR 2007
  4. Manuscript Received: 25 JAN 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (127K)

References

  • 1
    Gluckman E, Broxmeyer HE, Auerbacm AD et al. Haematopoietic reconstitution in a patient with Fanconi's anaemia by means of umbilical cord from an HLA-identical sibling. N Engl J Med 1989; 321:1174–1178.
  • 2
    Watt SM, Contreras M. Stem cell medicine: Umbilical cord blood and its stem cell potential. Semin Fetal Neonat Med 2005; 10:209–220.
  • 3
    Ballen KK. New trends in umbilical cord blood transplantation. Blood 2005; 105:3786–3792.
  • 4
    Rubinstein P. Why cord blood? Hum Immunol 2006; 67:398–404.
  • 5
    Brunstein CG, Wagner J. Umbilical cord blood transplantation and banking. Ann Rev Med 2006; 57:403–417.
  • 6
    Rubinstein P, Taylor PE, Scaradavou A et al. Unrelated placental cord blood for bone marrow reconstitution: Organisation of the placental blood program. Blood Cells 1994; 20:587–600.
  • 7
    Davey S, Armitage S, Rocha V et al. The London cord blood bank: Analysis of banking and transplantation outcome. Br J Haematol 2004; 125:358–365.
    Direct Link:
  • 8
    Warwick R, Armitage S. Cord blood banking. Best Pract Res Clin Obstet Gynaecol 2004; 18:995–1011.
  • 9
    Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program. In: MeyerEA, HannaK, GebbieK, eds. Washington DC: The National Academies Press, 2005;.
  • 10
    Rocha V, Wagner JE, Sobocinski K et al. Comparison of graft versus host disease in children transplanted with HLA identical sibling umbilical cord blood versus HLA identical sibling bone marrow transplant. N Engl J Med 2000; 342:1846–1854.
  • 11
    Cord Blood: Biology, Immunology, Banking and Clinical Transplantation. In: BroxmeyerHE, ed. Bethesda, MD: AABB Press, 2004;.
  • 12
    Schoemans H, Theunissen K, Maertens J et al. Adult umbilical cord blood transplantation: A comprehensive review. Bone Marrow Transplant 2006; 38:83–93.
  • 13
    Fernandez MN, Regidor C, Cabrera R et al. Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003; 31:535–544.
  • 14
    Magro E, Regidor C, Cabrera R et al. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party. Haematologica 2006; 91:640–648.
  • 15
    Reed W, Smith R, Dekovic F et al. Comprehensive banking of sibling donor cord blood for children with malignant and nonmalignant disease. Blood 2003; 101:351–357.
  • 16
    Walters MC, Quirolo L, Trachtenberg ET et al. Sibling donor cord blood transplantation for thalassemia major: Experience of the sibling donor cord blood program. Ann N Y Acad Sci 2005; 1054:206–213.
    Direct Link:
  • 17
    Cohen Y, Nagler A. Umbilical cord blood transplantation—how, when and for whom? Blood Rev 2004; 18:167–179.
  • 18
    Dyer C. Couple is given go-ahead to use embryo selection to help existing child. BMJ 2006; 332:1114.
  • 19
    Dyer C. HFEA widens its criteria for preimplantation genetic diagnosis. BMJ 2006; 332:1174.
  • 20
    Liao C, Li D, Wei J et al. Prenatal HLA-typing in beta-thalassemia before the collection of sibling cord blood. Prenat Diagn 2006; 26:89–90.
    Direct Link:
  • 21
    Qureshi N, Foote D, Walters MC et al. Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: A retrospective analysis. Ann N Y Acad Sci 2005; 1054:500–503.
    Direct Link:
  • 22
    A code of practices for tissue banks. Medicines Control Agency. London: UK Department of Health, 2001;.
  • 23
    Guidance for the Blood Transfusion Service in the United Kingdom. 7th ed. In: JamesV, ed. Norwich, U.K.: U.K. Government Stationery Office, 2005;.
  • 24
    International Standards for Cord Blood Collection, Processing, Testing, Banking, Selection and Release. 3rd ed. Omaha, NE: Foundation for the Accreditation of Hematopoietic Cell Therapy, 2006;.
  • 25
    Human Tissue Authority Codes of Practice. London: Department of Health, 2006;.
  • 26
    EU Tissues and Cells Directive (2004/23/E). Official Journal of the European Union. 2004; LI02:48–58.
  • 27
    Reference guide to consent for examination or treatment. London: UK Department of Health.
  • 28
    Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46:355–367.
    Direct Link:
  • 29
    Forsi L, Brown J, Railton D et al. HLA typing of chorionic villus samples: Assessment of potential for cord blood collection for the treatment of siblings. Eur J Immunogenet 2002; 29:363–368.
  • 30
    Verlinsky Y, Rechitsky S, Sharapova T et al. Preimplantation HLA testing. JAMA 2004; 291:2079–2085.
  • 31
    The Human Fertilisation and Embryology Authority Code of Practice. 6th ed. London: Department of Health, 2003;.
  • 32
    Allan DS, Keeney M, Howson-Jan K et al. Number of viable CD34 + cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29:967–972.
  • 33
    Watt SM, Austin E, Armitage S. Cryopreservation of haematopoietic stem/progenitor cells for therapeutic use. In: DayJG, StaceyGN, eds. Methods in Molecular Biology: Cryopreservation and Freeze-Drying Protocols. London: Humana Press Inc., 2006;.
  • 34
    Rules and Guidance for Pharmaceutical Manufacturers and Distributors. Annex 1: Manufacture of Sterile Medicinal Products. Norwich. U.K.: U.K. Department of Health Stationary Office, 2002;.
  • 35
    Patel R, Davey S, Turner D et al. The use of STR analysis to confirm identity of a cord blood unit prior to transplantation [Abstract]. Eur J Immunogenet 2003; 30:310a.
  • 36
    Nissen-Druey C, Tichelli A, Meyer-Monard S. Human hematopoietic colonies in health and disease. Acta Haematol 2005; 113:5–96.
  • 37
    Fisk NM, Roberts IA, Markwald R et al. Can routine commercial cord blood banking be scientifically and ethically justified? PLoS Med 2005; 2:e44.
  • 38
    Royal College of Obstetricians and Gynaecologists. Umbilical Cord Blood Banking. Scientific Advisory Committee Opinion Paper 2. 2006;.
  • 39
    Lubin BH, Shearer WT. Cord blood banking for potential future transplantation. Pediatrics 2007; 119:165–170.
  • 40
    Welte K, Costeas P, Brunoehler D et al. The world marrow donor association (WMDA) policy statement for the utility of autologous or family cord blood unit storage. the Netherlands: Leiden, 2006;.
  • 41
    Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100:1611–1618.
  • 42
    Hamza NS, Lisgaris M, Yadavalli G et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 2004; 124:488–498.
    Direct Link:
  • 43
    Montagna D, Locatelli F, Moretta A et al. T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation. Blood 2004; 103:4322–4329.
  • 44
    Wall DA, Noffsinger JM, Mueckl KA et al. Feasibility of an obstetrician-based cord blood collection network for unrelated donor umbilical cord blood banking. J Matern Fetal Med 1997; 6:320–323.
    Direct Link:
  • 45
    Surbek DV, Visca E, Steinmann C et al. Umbilical cord blood collection before placental delivery during cesarean delivery increases cord blood volume and nucleated cell number available for transplantation. Am J Obstet Gynecol 2000; 183:218–221.
  • 46
    Wada RK, Bradford A, Moogk M et al. Cord blood units collected at a remote site: A collaborative endeavor to collect umbilical cord blood through the Hawaii Cord Blood Bank and store the units at the Puget Sound Blood Center. Transfusion 2004; 44:111–118.
    Direct Link:
  • 47
    Solves P, Moraga R, Saucedo E et al. Comparison between two strategies for umbilical cord blood collection. Bone Marrow Transplant 2003; 31:269–273.
  • 48
    Guttridge M, Sidders C, Booth-Davey E et al. Factors affecting volume reduction and red blood cell depletion of bone marrow using the Cobe Spectra cell separator prior to haematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38:175–181.
  • 49
    Rodríguez L, Azqueta C, Azzalin S et al. Washing of cord blood grafts after thawing: High cell recovery using an automated and closed system. Vox Sang 2004; 87:165–172.
    Direct Link:
  • 50
    Armitage S, Fehily D, Dickinson A et al. Cord blood banking: Volume reduction of cord blood units using a semi-automated closed system. Bone Marrow Transplant 1999; 23:505–509.
  • 51
    Stanworth S, Warwick R, Fehily D et al. An international survey of unrelated umbilical cord blood banking. Vox Sang 2001; 80:236–243.
    Direct Link:
  • 52
    Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo A et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant 2006; 37:439–449.
  • 53
    Bielorai B, Hughes MR, Auerbach AD et al. Successful umbilical cord blood transplantation for Fanconi anemia using preimplantation genetic diagnosis for HLA-matched donor. Am J Hematol 2004; 77:397–399.
    Direct Link:
  • 54
    Grewal SS, Kahn JP, MacMillan ML et al. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 2004; 103:1147–1151.
  • 55
    Van de Velde H, Georgiou I, De Rycke M et al. Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum Reprod 2004; 19:700–708.
  • 56
    Bhattacharya A, Slatter MA, Chapman CE et al. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant 2005; 36:295–299.
  • 57
    Broxmeyer HE, Cooper S. High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 years. Clin Exp Immunol 1997; 107:45–53.
  • 58
    Krishnamurti L, Abel S, Maiers M et al. Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplant 2003; 31:547–550.
  • 59
    Gluckman E, Rocha V. Cord blood transplantation for children with acute leukaemia: A Eurocord registry analysis. Blood Cells Mol Dis 2004; 33:271–273.
  • 60
    Locatelli F, Rocha V, Reed W et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101:2137–2143.
  • 61
    Rocha V, Cornish J, Sievers EL et al. Comparison of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97:2962–2971.
  • 62
    Bitan M, Or R, Shapira MY et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 2006; 12:712–718.
View Full Article (HTML) Get PDF (127K)